Skip to main content

Table 1 Demographic data

From: Effect of helium pre- or postconditioning on signal transduction kinases in patients undergoing coronary artery bypass graft surgery

 

Controls

He-pre

He-post

He-PP

APC

p value

N

28

23

22

24

24

 

Age ± years

66.7 ± 7.0

62.8 ± 11.7

66.2 ± 7.8

66.2 ± 8.3

66.9 ± 7.6

0.47

Male (%)

22 (82)

21 (91)

20 (83)

20 (83)

21 (88)

0.88

Body Mass Index

28.4 ± 3.7

27.3 ± 2.7

26.7 ± 3.8

27.4 ± 3.7

27.7 ± 3.2

0.55

Risk factors

 Hypertension

16 (59)

9 (39)

13 (57)

10 (42)

13 (54)

0.52

 Hypercholesterolemia

6 (22)

11 (48)

10 (44)

5 (21)

14 (58)

0.023 a

 Smoking

13 (48)

10 (44)

8 (34)

11 (46)

10 (42)

0.89

 Family

12 (44)

9 (39)

7 (30)

9 (38)

13 (54)

0.56

 Myocardial infarction

7 (26)

10 (44)

8 (36)

10 (42)

8 (33)

0.71

 Cerebrovascular accident

0 (0)

0 (0)

0 (0)

1 (4)

0 (0)

0.40

Heart failure

 NYHA I

20 (74)

17 (74)

19 (86)

17 (71)

16 (70)

0.97

 NYHA II

2 (7)

2 (9)

1 (5)

2 (8)

3 (13)

0.97

 NYHA III

5 (19)

4 (17)

2 (9)

4 (17)

4 (17)

0.97

Ejection fraction

 >50 %

21 (81)

16 (73)

12 (57)

16 (67)

19 (90)

0.15

 30–50 %

5 (19)

6 (27)

7 (33)

4 (17)

1 (5)

0.15

Medication

 Salicylate

24 (86)

19 (83)

22 (92)

23 (96)

23 (92)

0.57

 Clopidogrel

9 (32)

9 (39)

12 (50)

9 (38)

4 (16)

0.15

 Statinb

27 (96)

23 (100)

24 (100)

20 (83)

21 (84)

0.04 b

 Beta-blockerc

19 (68)

22 (96)

24 (100)

21 (88)

21 (84)

0.008 c

 ACE inhibitor

10 (36)

8 (35)

10 (42)

4 (17)

11 (44)

0.30

 AT2 receptor blocker

6 (21)

1 (4)

5 (21)

5 (21)

3 (12)

0.40

 Calcium channel blocker

10 (36)

7 (30)

4 (17)

10 (42)

6 (24)

0.35

 Diuretics

6 (21)

4 (17)

4 (17)

7 (29)

4 (16)

0.77

 Nitrates

10 (36)

9 (39)

7 (29)

12 (50)

13 (52)

0.43

 Euroscore

3 (±2)

2 (±3)

3 (±3)

4 (±3)

1 (±3)

0.36

  1. Age and body mass index are presented as mean ± SD; Euroscore is presented as mean (±IQR); other data are numbers and percentage, n (%)
  2. aIn the control group significantly less patients with hypercholesterolemia were present
  3. bUse of statins was significantly lower in our control group compared to other groups
  4. cUse of beta-blockers was significantly lower in our control group compared to other groups
  5. He-Pre helium preconditioning; He-Post helium postconditioning; He-PP helium pre- and postconditioning; APC anesthetic preconditioning
  6. Age and Body Mass Index are presented as mean ± SD; Euroscore is presented as mean (±IQR); other data are numbers and percentage, n (%). In the control group significantly less patients with hypercholesterolemia were present. b Use of statins was significantly lower in our control group compared to other groups. c Use of beta-blockers was significantly lower in our control group compared to other groups